Reata Pharmaceuticals Announces Phase 3 Study of ADPKD Treatment
According to an article from PM360, Reata Pharmaceuticals has announced that its end-of-Phase 2 meeting with the Food and Drug Administration went according to plan. The American pharmaceutical company based…